Trump says agreements with major drugmakers will cut prescription prices and boost U.S. investment, but economists caution ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical ...

Millions of osteoporosis patients worldwide are set to benefit from a major international breakthrough, which will transform ...

La Jolla scientists are stepping into a national push to get new medicines from lab bench to bedside faster. The project, ...

It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...

A drug once designed for dengue virus, then quietly abandoned by industry, is suddenly back in the spotlight, and it may be ...

After raising $293 million in the IPO, Insilico Medicine aims to become “a massive source of innovative drugs for pharma ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...

Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...

Turning the tide on antibiotic resistance will require new ways of working, writes executive director of the Global Antibiotic Research & Development Partnership.

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...